212 related articles for article (PubMed ID: 29714603)
1. Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact.
Doerstling S; Hedberg P; Öhrvik J; Leppert J; Henriksen E
Ups J Med Sci; 2018 Jun; 123(2):86-93. PubMed ID: 29714603
[TBL] [Abstract][Full Text] [Related]
2. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
[TBL] [Abstract][Full Text] [Related]
3. Association of growth differentiation factor 15 with other key biomarkers, functional parameters and mortality in community-dwelling older adults.
Rothenbacher D; Dallmeier D; Christow H; Koenig W; Denkinger M; Klenk J;
Age Ageing; 2019 Jul; 48(4):541-546. PubMed ID: 30855645
[TBL] [Abstract][Full Text] [Related]
4. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
5. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies.
Xie S; Lu L; Liu L
Clin Cardiol; 2019 May; 42(5):513-523. PubMed ID: 30697778
[TBL] [Abstract][Full Text] [Related]
7. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals.
Eggers KM; Kempf T; Wallentin L; Wollert KC; Lind L
Clin Chem; 2013 Jul; 59(7):1091-8. PubMed ID: 23529704
[TBL] [Abstract][Full Text] [Related]
8. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Yusuf S; Siegbahn A; Wallentin L
Am Heart J; 2017 Aug; 190():94-103. PubMed ID: 28760218
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: A prospective study.
Bao X; Borné Y; Xu B; Orho-Melander M; Nilsson J; Melander O; Engström G
Am Heart J; 2021 Apr; 234():81-89. PubMed ID: 33421373
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study.
Frimodt-Møller M; von Scholten BJ; Reinhard H; Jacobsen PK; Hansen TW; Persson FI; Parving HH; Rossing P
PLoS One; 2018; 13(4):e0196634. PubMed ID: 29698460
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease.
Fluschnik N; Ojeda F; Zeller T; Jørgensen T; Kuulasmaa K; Becher PM; Sinning C; Blankenberg S; Westermann D
PLoS One; 2018; 13(5):e0197497. PubMed ID: 29771963
[TBL] [Abstract][Full Text] [Related]
12. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension.
Geenen LW; Baggen VJM; Kauling RM; Koudstaal T; Boomars KA; Boersma E; Roos-Hesselink JW; van den Bosch AE
Heart; 2020 Mar; 106(6):467-473. PubMed ID: 31492701
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.
Heringlake M; Charitos EI; Gatz N; Käbler JH; Beilharz A; Holz D; Schön J; Paarmann H; Petersen M; Hanke T
J Am Coll Cardiol; 2013 Feb; 61(6):672-81. PubMed ID: 23391200
[TBL] [Abstract][Full Text] [Related]
16. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study.
Rohatgi A; Patel P; Das SR; Ayers CR; Khera A; Martinez-Rumayor A; Berry JD; McGuire DK; de Lemos JA
Clin Chem; 2012 Jan; 58(1):172-82. PubMed ID: 22065155
[TBL] [Abstract][Full Text] [Related]
17. Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort.
Welsh P; Kimenai DM; Marioni RE; Hayward C; Campbell A; Porteous D; Mills NL; O'Rahilly S; Sattar N
Clin Chem Lab Med; 2022 Oct; 60(11):1820-1829. PubMed ID: 35976089
[TBL] [Abstract][Full Text] [Related]
18. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
[TBL] [Abstract][Full Text] [Related]
19. Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study.
Dallmeier D; Brenner H; Mons U; Rottbauer W; Koenig W; Rothenbacher D
Clin Chem; 2016 Jul; 62(7):982-92. PubMed ID: 27197673
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
